Link Pharma Chem GST demand cut to ₹16.3 lakh for FY22

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • GST Appellate Authority reduced Link Pharma Chem's FY22 tax demand to ₹16.3 lakh
  • Penalty amount decreased from ₹13.29 lakh to ₹2.05 lakh following the order
  • Dispute centered on GSTR1-GSTR3B mismatches and excess ITC on imports
  • Company plans to appeal the remaining liability despite reduced impact
powered bylight_fuzz_icon
53440799

*this image is generated using AI for illustrative purposes only.

Link Pharma Chem received an order from the GST Appellate Authority in Vadodara on October 12, 2026, significantly reducing its tax liability for the fiscal year 2021-22. The final demand was slashed from ₹1,32,94,322 to ₹16,29,852, while the associated penalty decreased from ₹13,29,433 to ₹2,05,605.

The regulatory filing disclosed that the initial dispute arose from alleged mismatches between tax liabilities declared in GSTR1 and payments made through GSTR3B. Additionally, authorities cited excess Input Tax Credit (ITC) availed on the import of goods that was not reflected in GSTR-2A.

Regulatory disclosure details

The company submitted this information under Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The order was issued by the GST Appellate Authority, Tribunal Vadodara.

Particulars Details
Authority GST Appellate Authority, Tribunal Vadodara
Original Demand ₹1,32,94,322
Revised Demand ₹16,29,852
Original Penalty ₹13,29,433
Revised Penalty ₹2,05,605
Period FY22

Financial impact and next steps

Link Pharma Chem stated that while the financial impact is limited to the revised demand, penalty, and interest amounts, there is no material impact on the company's operations or financial position. Despite the reduction, the company intends to file an appeal with the appropriate authority regarding the remaining liability.

What the numbers show

The appellate order resulted in a reduction of over 87% in the principal tax demand and nearly 85% in the penalty amount. This substantial decrease suggests the authority found significant merit in the company's defense against the initial claims of ITC mismatches and reporting discrepancies.

Historical Stock Returns for Link Pharma Chem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+3.49%+3.17%-5.86%-23.92%-28.48%

How might Link Pharma Chem's decision to appeal the remaining liability affect its short-term cash flow and provision for contingent liabilities?

Will this favorable appellate ruling influence the tax audit strategies or compliance protocols of other pharmaceutical companies facing similar GSTR-1 and GSTR-3B mismatches?

Does the significant reduction in penalties suggest a shift in the GST Appellate Authority's interpretation of Input Tax Credit discrepancies for importers in the chemical sector?

Link Pharma Chem re-appoints Satish G. Thakur as Chairman for three years

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Link Pharma Chem re-appointed Satish G. Thakur as Chairman and WTD for three years effective June 24, 2026
  • Rishikesh Thakur was re-appointed as Managing Director for a three-year term starting September 24, 2026
  • Shareholders approved all resolutions with 99.74% affirmative votes at the AGM on August 20, 2026
  • Voting participation stood at 58.97% of eligible shares, with promoters voting unanimously in favor
powered bylight_fuzz_icon
48779116

*this image is generated using AI for illustrative purposes only.

Link Pharma Chem Limited has confirmed the re-appointment of Mr. Satish G. Thakur as Chairman and Whole-time Director for a three-year term effective June 24, 2026. The resolution was passed during the company’s 41st Annual General Meeting (AGM) held on August 20, 2026.

The company also re-appointed Mr. Rishikesh Thakur as Managing Director for a three-year term effective September 24, 2026. Shareholders approved all six ordinary and special resolutions with overwhelming support, securing 99.74% affirmative votes across the board. The virtual meeting was scrutinized by M/s. Vijay Bhatt & Co., Company Secretaries, Vadodara.

Voting Participation

As per the record date of August 13, 2026, the company had a total of 6,004 shareholders. Of these, 47 members attended the meeting through video conferencing, comprising three promoters and 44 public shareholders.

The total number of votes polled was 2,618,698, representing 58.97% of the outstanding shares held by eligible voters. The promoter group held 2,326,936 shares and voted in favor of all resolutions. Public non-institutional shareholders polled 291,762 votes, with 284,823 cast in favor and 6,939 against.

Shareholder Category Shares Held Votes Polled % Polling Votes in Favor Votes Against
Promoter & Group 2,326,936 2,326,936 100.00% 2,326,936 -
Public-Institution 700 - - - -
Public-Non Institution 2,112,932 291,762 13.81% 284,823 6,939
Total 4,440,568 2,618,698 58.97% 2,611,759 6,939

Resolutions Passed

All resolutions were passed with the requisite majority. No invalid votes were recorded during the process.

Resolution Type Particulars Status
Ordinary Adoption of Audited Financial Statements for FY ended March 31, 2026 Passed
Ordinary Re-appointment of Mr. Satish Thakur retiring by rotation Passed
Ordinary Ratification of remuneration of Cost Auditors for FY26-27 Passed
Ordinary Appointment of Secretarial Auditor Passed
Special Re-appointment of Mr. Satish G. Thakur as Chairman & WTD Passed
Special Re-appointment of Mr. Rishikesh Thakur as Managing Director Passed

Management Profile & Attendance

Mr. Satish G. Thakur, who holds a B.Sc. and L.Tech degree, has been associated with the company since its incorporation. He brings more than 43 years of experience in the industry, with expertise in project design and development. He is the father of Mr. Rishikesh Thakur, Managing Director.

Key management personnel present included Mr. Rishikesh Thakur, Managing Director; Mrs. Rachna Ghai, Independent Director; Mr. Rohit J Shah, Independent Director; and Mrs. Rangoli S Gada, Independent Director. Mr. Sanjib Dutta, Chief Financial Officer, and Mrs. Komal Bhojwani, Company Secretary, were also in attendance.

Mr. Satish G. Thakur chaired the proceedings. Five shareholders participated in the question-and-answer session, with queries addressed by the Managing Director.

Mr. Rishikesh Thakur holds a degree in B. Eng. in Polymer from London Metropolitan University. He has more than 15 years of experience in the chemical business, including manufacturing, research and development, and project development.

The Company Secretary confirmed that the scrutinizer’s report and e-voting results have been submitted to the BSE within the stipulated timeframe.

Historical Stock Returns for Link Pharma Chem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+3.49%+3.17%-5.86%-23.92%-28.48%

How might the leadership transition from Satish G. Thakur to Rishikesh Thakur influence Link Pharma Chem's strategic direction in the polymer and chemical sectors?

What specific growth initiatives or capital expenditure plans are expected to be prioritized under the new three-year term of the current management team?

Given the low participation rate (13.81%) among public non-institutional shareholders, does the company plan to implement measures to improve minority shareholder engagement in future AGMs?

More News on Link Pharma Chem

1 Year Returns:-23.92%